Development of serum-free media for cell growth and production of viruses/viral vaccines--safety issues of animal products used in serum-free media
- PMID: 12678248
Development of serum-free media for cell growth and production of viruses/viral vaccines--safety issues of animal products used in serum-free media
Abstract
The development of media free of serum and animal or human proteins is of utmost importance for increasing the safety of biological produced for therapy and vaccination. The main drawback associated with the use of serum or animal-derived substances for animal cell technology is the potential introduction of contaminants and, in particular, adventitious agents into the process and thus potentially also into the final product. This fact led to an increased effort to replace serum-containing by serum-free media. In most cases, these media are supplemented with purified proteins, peptones, or hydrolysates, mainly of animal or human origin. Although such serum-free media are more defined than serum-containing media, the risk of the introduction of viruses by using animal-derived substances is still present, signifying that only a complete replacement of animal-derived substances by non-animal-derived products leads to a relatively safe serum-free medium. In several examples the potential of serum-free media and media free of any animal-derived component in supporting growth of cell lines of interest for virus production (such as Vero or MDCK) and production of viruses, and, in particular, of influenza virus for vaccine production, are presented and discussed with respect to the classical production processes.
Similar articles
-
Safety issues of animal products used in serum-free media.Dev Biol Stand. 1999;99:167-80. Dev Biol Stand. 1999. PMID: 10404888 Review.
-
Production of influenza virus in serum-free mammalian cell cultures.Dev Biol Stand. 1999;98:23-37; discussion 73-4. Dev Biol Stand. 1999. PMID: 10494957
-
A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.Vaccine. 2007 May 10;25(19):3879-89. doi: 10.1016/j.vaccine.2007.01.086. Epub 2007 Feb 5. Vaccine. 2007. PMID: 17307281
-
Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.Vaccine. 2006 Apr 12;24(16):3261-72. doi: 10.1016/j.vaccine.2006.01.019. Epub 2006 Jan 19. Vaccine. 2006. PMID: 16472544
-
The development, benefits and disadvantages of serum-free media.Dev Biol Stand. 1999;99:157-66. Dev Biol Stand. 1999. PMID: 10404887 Review.
Cited by
-
Structural and Biochemical Features of Human Serum Albumin Essential for Eukaryotic Cell Culture.Int J Mol Sci. 2021 Aug 5;22(16):8411. doi: 10.3390/ijms22168411. Int J Mol Sci. 2021. PMID: 34445120 Free PMC article. Review.
-
Production of inactivated influenza H5N1 vaccines from MDCK cells in serum-free medium.PLoS One. 2011 Jan 24;6(1):e14578. doi: 10.1371/journal.pone.0014578. PLoS One. 2011. PMID: 21283675 Free PMC article.
-
Growth characteristics of canine pathogenic viruses in MDCK cells cultured in RPMI 1640 medium without animal protein.Vaccine. 2006 Mar 10;24(11):1744-8. doi: 10.1016/j.vaccine.2005.07.114. Epub 2005 Oct 25. Vaccine. 2006. PMID: 16271422 Free PMC article.
-
Evaluation of recombinant human transferrin (DeltaFerrin(TM)) as an iron chelator in serum-free media for mammalian cell culture.Cytotechnology. 2006 May;51(1):29-37. doi: 10.1007/s10616-006-9011-x. Epub 2006 Aug 3. Cytotechnology. 2006. PMID: 19002892 Free PMC article.
-
Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells.Biotechnol J. 2009 Feb;4(2):186-201. doi: 10.1002/biot.200800241. Biotechnol J. 2009. PMID: 19226552 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources